Recognizing the Shortcomings in Life Sciences SaaS CRM in 2017

SaaS CRM vendors are creating runaway recurring costs and exit barriers for life science companies in 2017

The CRM market in life sciences is dominated by a few specialized vertical-focused vendors whose solutions re¬flect an increasingly obsolete monolithic enterprise architecture that does not align with the macro trends, driving new decision-making priorities in life sciences.


As the life science industry evolves into 2020, new technology, stakeholders, and economic (macro) trends are limiting the effectiveness of the existing CRMs for profitable and sustainable growth. Meanwhile, vendors continue to innovate new SaaS products that only grow recurring fees and force technology parity across the life science industry.


This whitepaper outlines the significant macro trends impacting life science in 2017, and contrast those with the current limitations of major CRM vendors to consider before your next technology replacement cycle.

About Indegene


Indegene enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations, and medical expertise and drive better health and business outcomes. Indegene’s IP-based solutions help clients drive revenues and productivity by making transformational leaps in digitalization of customer engagement, health reform, healthcare cost reduction, and health outcomes improvement.

Contact Information

Indegene Omnipresence, Inc

600 Third Avenue, 2nd Floor, New York, NEW YORK, 10016

Useful Links


> Request a demo


> About us

> News 

> Resources

© Indegene  |  About Indegene  | Privacy Policy

Join the Conversation